FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approves Chartwell RX, LLC's supplemental application for cilostazol (generic) under ANDA077021, enabling market authorization for a generic cilostazol prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

SUPPL AP for CILOSTAZOL (CILOSTAZOL)